CDK2 Activation in Mouse Epidermis Induces Keratinocyte Proliferation but Does Not Affect Skin Tumor Development

Por Macias, Everardo, Miliani de Marval, Paula L., De Siervi, Adriana, Conti, Claudio J., Senderowicz, Adrian M., Rodriguez-Puebla, Marcelo L.
Publicado em 2008

Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b)

Por Rojas, Paola, Benavides, Fernando, Blando, Jorge, Perez, Carlos, Cardenas, Kim, Richie, Ellen, Knudsen, Erik S., Johnson, David G., Senderowicz, Adrian M., Rodriguez-Puebla, Marcelo L., Conti, Claudio J.
Publicado em 2009

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

Por Sausville, Edward, LoRusso, Patricia, Carducci, Michael, Carter, Judith, Quinn, Mary F., Malburg, Lisa, Azad, Nilofer, Cosgrove, David, Knight, Richard, Barker, Peter, Zabludoff, Sonya, Agbo, Felix, Oakes, Patricia, Senderowicz, Adrian
Publicado no Cancer Chemother Pharmacol (2014)

A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms

Por Figg, William D., Monga, Manish, Headlee, Donna, Shah, Avni, Chau, Cindy H., Peer, Cody, Messman, Richard, Elsayed, Yusri A., Murgo, Anthony J., Melillo, Giovanni, Ryan, Qin C., Kalnitskiy, Mikhail, Senderowicz, Adrian M., Hollingshead, Melinda, Arbuck, Susan G., Sausville, Edward A.
Publicado no Cancer Chemother Pharmacol (2014)